StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SpringWorks Therapeutics, Inc.
NasdaqGS:SWTX
Sector
Industries
Location
Market Cap
USD 3.54 B
Share Price
USD 46.99
Avg Daily Volume
4,950,914
Change (1 day)
0.00%
Change (1 year)
26.08%
Change (YTD)
30.06%
SpringWorks Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.95
SpringWorks Therapeutics, Inc. Revenue Per Share is USD 2.95 for the Trailing 12 Months (TTM) ending March 31, 2025, a 431.03% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
SpringWorks Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 0.56, a 151.44% change year over year.
-
SpringWorks Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 0.22, a 3,538.61% change year over year.
-
SpringWorks Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.01, a -99.22% change year over year.
-
SpringWorks Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.78.
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Thermo Fisher Scientific Inc.
USD 418.70
TMO
-10.63
-2.48%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
Novartis AG
USD 122.10
NOVN.SW
-1.46
-1.18%
Abbott Laboratories
USD 133.70
ABT
-0.74
-0.55%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Thermo Fisher Scientific Inc.
USD 418.70
TMO
-10.63
-2.48%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Boston Scientific Corporation
USD 103.83
BSX
-0.49
-0.47%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Vertex Pharmaceuticals Incorporated
USD 459.41
VRTX
-0.21
-0.05%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
CSL Limited
USD 160.25
CSL.AX
-0.71
-0.44%
Siemens Healthineers AG
USD 54.56
SHL.DE
-0.44
-0.81%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%